Avidity Biosciences Receives IND Clearance from FDA to Proceed with the Phase 1/2 MARINA ...

Retrieved on: 2021-08-02 16:52:27

Tags for this article:

Branches of biology

RNA

Biology

Molecular biology

Neurological disorders

Biotechnology

Myotonic dystrophy

DM1

Myotonin-protein kinase

Facioscapulohumeral muscular dystrophy

DMPK

Myotonia

Avidity Biosciences Inc.

Click the tags to see associated articles and topics

Avidity Biosciences Receives IND Clearance from FDA to Proceed with the Phase 1/2 MARINA .... View article details on hiswai:

Excerpt

AOC 1001 consists of a proprietary monoclonal antibody that binds to the transferrin receptor 1 (TfR1) conjugated with a small interfering RNA (siRNA) ...

Article found on: pipelinereview.com

View Original Article